Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Withdrawn1
Suspended1
Completed1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

withdrawn125%
suspended125%
completed125%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
recruitingnot_applicable

Transrectal Ultrasound Robot-Assisted Prostate Biopsy

NCT02871726
suspended

Utility of Adding MR Fusion to Standard US Guided Prostate Biopsy

NCT05064111
withdrawnnot_applicable

Correlation of Imaging Findings With Clinical Findings and Patient Outcomes in Prostate Cancer

NCT03122470
completednot_applicable

Advanced Magnetic Resonance Imaging (MRI) in Men With Suspected Prostate Cancer

NCT02745496

Clinical Trials (4)

Showing 4 of 4 trials
NCT02871726Not Applicable

Transrectal Ultrasound Robot-Assisted Prostate Biopsy

Recruiting
NCT05064111

Utility of Adding MR Fusion to Standard US Guided Prostate Biopsy

Suspended
NCT03122470Not Applicable

Correlation of Imaging Findings With Clinical Findings and Patient Outcomes in Prostate Cancer

Withdrawn
NCT02745496Not Applicable

Advanced Magnetic Resonance Imaging (MRI) in Men With Suspected Prostate Cancer

Completed

All 4 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
4